NCT04309383View on ClinicalTrials.gov

ShuntCheck Performance Characteristics in Asymptomatic Pseudotumor Cerebri Patients

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

January 31, 2025

Conditions
Pseudotumor Cerebri
Interventions
DIAGNOSTIC_TEST

ShuntCheck

The intervention is an FDA-cleared device utilizing a transcutaneous thermal convection to analyze shunt flow.

Trial Locations (1)

33606

RECRUITING

University of South Florida Department of Neurological Surgery and Brain Repair, Tampa

Sponsors

Collaborators (1)

NeuroDx Development
All Listed Sponsors
collaborator

NeuroDx Development

INDUSTRY

lead

University of South Florida

OTHER

NCT04309383 - ShuntCheck Performance Characteristics in Asymptomatic Pseudotumor Cerebri Patients | Biotech Hunter | Biotech Hunter